Skip to main content
Market intelligence
XENEHealthcare

Xenon Pharmaceuticals Inc insider activity

In the last 90 days, 2 corporate insiders purchased $1,681,140 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$1,681,140
Corporate buyers
2
Latest transaction
Sep 30, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 30, 2026Thomas Patrick KellyChief Financial OfficerOpen Market Purchase15,000$37.32$559,740
Sep 30, 2026Ian MortimerPRESIDENT & CEOOpen Market Purchase30,000$37.38$1,121,400
Aug 28, 2026Christopher John KenneyChief Medical OfficerSale7,068$60.25$425,829